Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

AutoImmune reports preliminary results from phase II trials of Colloral

May 14, 1997

Tularik receives U.S. patent relating to enzyme associated with inflammation

May 14, 1997

Panax to acquire CorBec

May 13, 1997

BioSpecifics receives grant to develop collagenase injection for Dupuytren's disease

May 12, 1997

BioCryst receives milestone payment from Torii

May 7, 1997

British Biotech and SynPhar sign research collaboration

May 7, 1997

Biosource Technologies awarded NIH grant to develop melanin as an antiinflammatory compound

May 6, 1997

Biomatrix's viscosupplementation product to be distributed by Bayer

May 2, 1997

Clodronate shows comparable efficacy to indomethacin in a rat model of arthritis

May 2, 1997

Potent, selective and orally active COX-2 inhibitors from Parke-Davis

April 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...